China SFDA Vows To Find, Prosecute ‘Made In India’ Chinese Drug Makers
This article was originally published in PharmAsia News
Executive Summary
China's State FDA says it will investigate allegations that some drugs are being made in China for sale abroad and labeled "Made in India." The action stemmed from anti-malaria drugs seized by Nigeria's Drug Regulatory Authority, enough to treat 642,000 adults. An SFDA spokesperson said the agency is sending investigators to Chinese provinces where the drugs allegedly were made. Another official said the guilty companies would be prosecuted, but advised pharmacy companies in other countries to deal only with Chinese firms recognized by SFDA. (Click here for more
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.